Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare
Denali Therapeutics Inc. Cash on Hand 2016–2025
Denali Therapeutics Inc. annual/quarterly cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Denali Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 205.3M, a 17.36% increase year-over-year.
- Denali Therapeutics Inc. cash on hand for 2025 were 205.3M, a 17.36% increase from 2024.
- Denali Therapeutics Inc. cash on hand for 2024 were 175.0M, a 37.65% increase from 2023.
- Denali Therapeutics Inc. cash on hand for 2023 were 127.1M, a 41.71% decrease from 2022.
- Denali Therapeutics Inc. cash on hand for 2022 were 218.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Denali Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $205 |
| 2024 | $175 |
| 2023 | $127 |
| 2022 | $218 |
| 2021 | $293 |
| 2020 | $507 |
| 2019 | $79 |
| 2018 | $77 |
| 2017 | $218 |
| Denali Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $205 |
| 2024-12-31 | $175 |
| 2023-12-31 | $127 |
| 2022-12-31 | $218 |
| 2021-12-31 | $293 |
| 2020-12-31 | $507 |
| 2019-12-31 | $79 |
| 2018-12-31 | $77 |
| 2017-12-31 | $218 |
Denali Therapeutics Inc. Cash on Hand — FAQ
Denali Therapeutics Inc. (DNLI) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNLI's cash on hand history?
The chart and table above show Denali Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.